Nortec Quimica (BSP:NRTQ3) Cyclically Adjusted Revenue per Share: R$0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nortec Quimica Cyclically Adjusted Revenue per Share?

Nortec Quimica BSP:NRTQ3 Cyclically Adjusted Revenue per Share is R$0.00 as of Dec. 2025.

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Nortec Quimica's adjusted revenue per share for the three months ended in Dec. 2025 was R$0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$0.00 for the trailing ten years ended in Dec. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-24), Nortec Quimica's current stock price is R$0.00. Nortec Quimica's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 was R$0.00. Nortec Quimica's Cyclically Adjusted PS Ratio of today is .


Nortec Quimica  (BSP:NRTQ3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Nortec Quimica Cyclically Adjusted Revenue per Share Related Terms


Nortec Quimica Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Nortec Quimica's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nortec Quimica Cyclically Adjusted Revenue per Share Chart

Nortec Quimica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nortec Quimica Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nortec Quimica Cyclically Adjusted Revenue per Share Competitor Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nortec Quimica's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nortec Quimica Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nortec Quimica's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Nortec Quimica's Cyclically Adjusted PS Ratio falls into.



Nortec Quimica Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nortec Quimica's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0/171.7653*171.7653
=0.000

Current CPI (Dec. 2025) = 171.7653.

Nortec Quimica Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 2.450 104.247 4.037
201603 3.062 106.979 4.916
201606 3.386 108.851 5.343
201609 2.613 109.986 4.081
201612 2.482 110.802 3.848
201703 2.709 111.869 4.159
201706 2.709 112.115 4.150
201709 3.018 112.777 4.597
201712 3.656 114.068 5.505
201803 3.832 114.868 5.730
201806 4.135 117.038 6.069
201809 4.724 117.881 6.883
201812 3.182 118.340 4.619
201903 3.192 120.124 4.564
201906 3.487 120.977 4.951
201909 3.602 121.292 5.101
201912 4.158 123.436 5.786
202003 4.422 124.092 6.121
202006 4.952 123.557 6.884
202009 3.914 125.095 5.374
202012 6.007 129.012 7.998
202103 4.895 131.660 6.386
202106 5.594 133.871 7.177
202109 6.134 137.913 7.640
202112 5.340 141.992 6.460
202203 4.371 146.537 5.124
202206 6.038 149.784 6.924
202209 4.818 147.800 5.599
202212 2.307 150.207 2.638
202303 6.148 153.352 6.886
202306 5.517 154.519 6.133
202309 3.543 155.464 3.915
202312 1.880 157.148 2.055
202403 4.177 159.372 4.502
202406 4.768 161.052 5.085
202409 5.648 162.342 5.976
202412 6.103 164.740 6.363
202503 3.323 168.102 3.395
202506 4.133 169.670 4.184
202512 0.000 171.765 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$0.00 mean?
Nortec Quimica (BSP:NRTQ3) has a Cyclically Adjusted Revenue per Share of R$0.00 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Nortec Quimica and its competitors.
Is Nortec Quimica's Cyclically Adjusted Revenue per Share too high?
Nortec Quimica's current Cyclically Adjusted Revenue per Share is R$0.00.
How does Nortec Quimica's Cyclically Adjusted Revenue per Share compare to competitors?
Nortec Quimica's Cyclically Adjusted Revenue per Share of R$0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Nortec Quimica and its competitors. Nortec Quimica's current Cyclically Adjusted Revenue per Share is R$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nortec Quimica stock overvalued right now?
Nortec Quimica (BSP:NRTQ3) has a current Cyclically Adjusted Revenue per Share of R$0.00. The current Cyclically Adjusted Revenue per Share is R$0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Nortec Quimica (BSP:NRTQ3), the current Cyclically Adjusted Revenue per Share is R$0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nortec Quimica Business Description

Address Rua 177, 200 A, B, C and D, Industrial District, Mantiquira, Xerem, Duque de Caixas, RJ, BRA, 25250-612
Nortec Quimica SA is engaged in the research and development of product technologies, provision of technical assistance services in third-party commercial, technological and production areas.